» Articles » PMID: 11228228

Prevalence of Diabetes Mellitus, Hypertension and Cardiac Complaints in a Follow-up Study of a Dutch PCOS Population

Overview
Journal Hum Reprod
Date 2001 Mar 3
PMID 11228228
Citations 57
Authors
Affiliations
Soon will be listed here.
Abstract

The aim of this study was to investigate the prevalence of diabetes mellitus, hypertension and cardiac complaints in a Dutch population with polycystic ovarian syndrome (PCOS) and to compare the results with the prevalence of these conditions in the Dutch female population, as retrieved from the Netherlands Health Interview Survey of Statistics Netherlands. A total of 346 PCOS patients were interviewed by telephone, with a mean age of 38.7 years (range 30.3--55.7) and a mean body mass index of 24.4 (range 17.5--55.8). Diabetes occurred in eight (2.3%), hypertension in 31 (9%) and cardiac complaints in three (0.9%) of the women. The prevalence of diabetes and hypertension differed significantly from the prevalence of these conditions in the Dutch female population (both P < 0.05). In PCOS women aged 45--54 years (n = 32) the prevalence of diabetes was four times higher (P < 0.05) and of hypertension 2.5 times higher (P < 0.01) than the prevalence of these conditions in the corresponding age group of the Dutch female population. Hypertension also occurred significantly (P < 0.05) more in the younger (35--44 years) PCOS group (n = 233), but this age group was significantly more obese (P < 0.01) when compared with figures of obesity of the Dutch female population. In conclusion, our data show that in a follow-up study of a relatively lean PCOS population, the prevalence of diabetes mellitus and hypertension was increased when compared with the Dutch female population, especially in women aged 45--54 years.

Citing Articles

Evaluating the Levels of Mental Stress, Salivary Oxidative Stress, Body Mass Index, and Waist-to-Hip Ratio in University Students With and Without Polycystic Ovary Syndrome and Their Impact on Academic Performance.

Goyal A, Kruthiventi H Cureus. 2024; 16(10):e71488.

PMID: 39544592 PMC: 11560864. DOI: 10.7759/cureus.71488.


SHBG Levels Do Not Correlate with Insulin Levels in PCOS with Appropriate Fasting Insulin Sensitivity.

Tuu L, Nas K, Torok M, Varbiro S J Clin Med. 2024; 13(3).

PMID: 38337532 PMC: 10856642. DOI: 10.3390/jcm13030838.


Concerns and expectations in women with polycystic ovary syndrome vary across age and ethnicity: findings from PCOS Pearls Study.

Elghobashy M, Lau G, Davitadze M, Gillett C, OReilly M, Arlt W Front Endocrinol (Lausanne). 2023; 14:1175548.

PMID: 37621648 PMC: 10446892. DOI: 10.3389/fendo.2023.1175548.


Obesity-associated cardiometabolic complications in polycystic ovary syndrome: The potential role of sodium-glucose cotransporter-2 inhibitors.

Pruett J, Romero D, Yanes Cardozo L Front Endocrinol (Lausanne). 2023; 14:951099.

PMID: 36875461 PMC: 9974663. DOI: 10.3389/fendo.2023.951099.


Sodium-Glucose Cotransporter-2 Inhibition Benefits in Cardiorenal Risk in Men and Women.

Pruett J, Lirette S, Romero D, Yanes Cardozo L J Endocr Soc. 2023; 7(2):bvac191.

PMID: 36601021 PMC: 9795477. DOI: 10.1210/jendso/bvac191.